Boehringer Ingelheim

Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
Mon, 02/27/23 - 10:02 am
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
New Report Reveals Pharmaceutical Industry Social Media Pioneers
LBB Online
Fri, 02/24/23 - 08:52 am
Ogilvy Health
social media
Bristol Myers Squibb
Boehringer Ingelheim
Roche
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Roche, Boehringer tap biosensor firms for patient studies
Pharmaphorum
Thu, 01/26/23 - 10:58 am
Roche
Boehringer Ingelheim
patient monitoring
biosensors
clinical trials
Sysnav Healthcare
Strados Labs
Boehringer, Takeda make it into global top 15 employer list
Pharmaphorum
Tue, 01/17/23 - 10:25 am
Boehringer Ingelheim
Takeda
Top Employers
Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year
Endpoints
Wed, 01/4/23 - 05:16 pm
Sanofi
Boehringer Ingelheim
Zantac
legal
Boehringer Ingelheim deepens its collaboration with Click Therapeutics in a deal worth $460M
Endpoints
Mon, 12/19/22 - 10:07 pm
Boehringer Ingelheim
Click Therapeutics
digital therapeutics
schizophrenia
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Wed, 12/7/22 - 11:40 pm
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
Jardiance
pediatri
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Eli Lilly
Boehringer Ingelheim
chronic kideny disease
Jardiance
Farxiga
AstraZeneca
Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3
Pharmaphorum
Thu, 10/27/22 - 10:41 am
Boehringer Ingelheim
BI 1015550
IPH
Boehringer and Surrozen Seek Retinal Therapies Along the Wnt Pathway
BioSpace
Fri, 10/7/22 - 10:39 am
Boehringer Ingelheim
Surrozen
Wnt pathway
retinal diseases
R&D
Boehringer Ingelheim preps FDA submission with new data in rare pediatric lung disease
Endpoints
Tue, 09/6/22 - 05:00 pm
Boehringer Ingelheim
nintedanib
Ofev
Boehringer reports Phase III data for nintedanib in interstitial lung disease
Clinical Trials Arena
Tue, 09/6/22 - 10:45 am
Boehringer Ingelheim
clinical trials
nintedanib
interstitial lung disease
Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod
Fierce Pharma
Fri, 09/2/22 - 12:19 pm
Boehringer Ingelheim
FDA
dermatology
GPP
Spevigo
In damage control mode, Perrigo clarifies that it's off the hook in key Zantac case
Fierce Pharma
Thu, 08/18/22 - 11:18 pm
Perrigo
Boehringer Ingelheim
GSK
legal
Zantac
Boehringer takes on antimicrobial resistance with Evotec, bioMérieux JV
Pharmaforum
Wed, 07/6/22 - 11:00 am
Boehringer Ingelheim
Evotec
Biomerieux
antimicrobial resistance
antibiotic resistance
Aurobac Therapeutics
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
Tue, 07/5/22 - 11:52 pm
China
biotech
WuXi Biologics
Boehringer Ingelheim
Siemens Healthineers
AstraZeneca
Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers
BioSpace
Tue, 06/28/22 - 10:40 am
Boehringer Ingelheim
BiomX
biomarkers
microbiome
IBD
Boehringer Ingelheim to incubate biotechs with Hong Kong R&D leader
Endpoints
Fri, 06/17/22 - 09:51 am
Boehringer Ingelheim
R&D
Hong Kong
incubators
Boehringer Ingelheim Signs Option to Acquire Immunology Partner, Trutino Biosciences
BioSpace
Wed, 06/15/22 - 10:56 am
Boehringer Ingelheim
Trutino Biosciences
M&A
cancer

Pages